Unprovoked venous thromboembolism: Should we be looking for cancer?
Larsen, T.B.
Ugeskrift for Laeger 177(48): V67480
2015
ISSN/ISBN: 1603-6824 PMID: 26617165 Document Number: 684031
Document emailed within 1 workday
Related Documents
Carcaterra, A.; Serratrice, J.; Righini, M.; Robert-Ebadi, H. 2018: Unprovoked venous thromboembolism : should we look for occult cancer ? Revue Medicale Suisse 14(623): 1840-1843Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Abdel-Razeq, H.N.; Radwi, G.R. 2004: Duration of anticoagulation after first episode of unprovoked venous thromboembolism Saudi Medical Journal 25(11): 1776; Author Reply 1776-7
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Rasmussen, M.S.; Münster, A.-M.B. 2010: Cancer and venous thromboembolism Ugeskrift for Laeger 172(12): 958
Sander, R.W.; Flynn, C.A. 1998: Venous thromboembolism and cancer Journal of Family Practice 47(1): 13-14
Liu, F-fang.; Zhai, Z-guo.; Yang, Y-hua.; Wang, J.; Wang, C. 2013: Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93(24): 1860-1863
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Henrik T. Sørensen; Søren Johnsen, P.; Bente Nørgård; Zacharski, L.R.; Baron, J.A. 2003: Cancer and Venous Thromboembolism: a Multidisciplinary Approach Clinical Laboratory 49(11-12): 615-623
Meyer, G. 2011: Secondary prevention of venous thromboembolism in patients with cancer La Revue du Praticien 61(9): 1249-1251
Thomas, A.Z.; Kamat, A.M. 2014: Venous thromboembolism and bleeding risk in bladder cancer Oncology 28(10): 854
Lyman, G.H. 2012: The incidence of venous thromboembolism in cancer patients: a real-world analysis Clinical Advances in Hematology and Oncology: H&o 10(1): 40-42
Longol, F.; Mansueto, G.; Zivil, A. 2007: Satellite Symposium AIOM, Palermo, 2007. Venous thromboembolism and cancer Tumori 93(6): Suppl. 1-10
Tsutsumi, S.; Yajima, R.; Tabe, Y.; Takaaki, T.; Fujii, F.; Morita, H.; Kigure, W.; Kato, T.; Yamauchi, H.; Suto, T.; Asao, T.; Kuwano, H. 2012: The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer Hepato-Gastroenterology 59(120): 2477-2479
Djulbegovic, B. 2010: Management of venous Thromboembolism in cancer: a brief review of risk-benefit approaches and guidelines' recommendations Journal of Supportive Oncology 8(2): 84-91
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Monreal, M.; Fernandez-Llamazares, J.; Perandreu, J.; Urrutia, A.; Sahuquillo, J.C.; Contel, E. 1997: Occult cancer in patients with venous thromboembolism: which patients, which cancers Thrombosis and Haemostasis 78(5): 1316-1318